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Abstract. Twenty-six benzocycloheptoxazine derivatives were
investigated for their effect on nitric oxide (NO) production by
lipopolysaccharide (LPS)-stimulated mouse macrophage-like
RAW 264.7 cells. Benzo[b]cyclohepta[e][1,4]thiazine most
effectively inhibited the LPS-stimulated NO production at
noncytotoxic concentrations. 6H-Benzo[b]cyclohepta[e][1,4]-
diazine cation, and benzo[b]cyclohepta[e][1,4]oxazine and its
6-bromo derivative also efficiently inhibited the LPS-stimulated
NO production. Another sixteen benzo[b]cyclohepta[e]-
[1,4]oxazine derivatives, 14H-[1,4]benzoxazino[3’,2’:3,4]-
cyclohepta[1,2-b][1,4]benzoxazine and its 7-bromo- and
7-isopropyl derivatives were slightly less active (selectivity
index (SI)=8.3-66). Bromination of benzo[b]cyclohepta[e][1,4]-
thiazine, benzo[b]cyclohepta[e][1,4]oxazine and 2-methyl-
benzo[b]cyclohepta[e][1,4]oxazine at C-6, C-8 or C-10
positions resulted in the significant reduction of the inhibitory
activity. The observed inhibitory activity of benzo[b]cyclohepta-
[e][1,4]thiazine and its 6,8-dibromo derivatives were not due to
the reduction of the intracellular level of inducible NO synthase
protein (based on Western blot analysis), nor to NO scavenging
activity (based on ESR spectroscopy). These results suggest the
possible anti-inflammatory action of benzocyclo-heptoxazines
via inhibition of LPS-activated macrophages.
Hinokitiol and its related compounds with a tropolone
skeleton (1-3) have been reported to exhibit various
biological activities such as antimicrobial (4), antifungal (5)
and phytogrowth-inhibitory activity (6, 7), cytotoxic effects
on mammalian tumor cells (8, 9) and inhibitory effects on
catechol-O-methyltransferase (10) and metalloproteases (4).
Hinokitiol acetate did not exhibit cytotoxic activity (9),
antimicrobial activity nor metalloprotease inhibition (4),
suggesting that these biological effects of hinokitiol-related
compounds may result from the metal chelation of the
carbonyl group at C-1 with the hydroxyl group at C-2 in the
tropolone skeleton. Tropolones with a phenolic OH group,
hinokitiol, its tosylate and methyl ethers have been found to
exhibit higher tumor-specific cytotoxic activity, while
2-aminotropolone showed the highest tumor specificity and
induced apoptosis in the human promyelocytic leukemia
HL-60 cell line, possibly by radical-mediated redox reaction
(11). 2,4-Dibromo-7-methoxytropone inhibited nitric oxide
(NO) production by lipopolysaccharide (LPS)-stimulated
mouse macrophage-like RAW 264.7 cells via the inhibition
of inducible NO synthase (iNOS) expression, rather than via
the radical-mediated mechanism (12).
Differing from unreactive heterocyclic-annulated tropylium
compounds, cyclohepta[b][1,4]benzoxazines and their S- and
O-analogues are usually very reactive, especially towards 1,4-
difunctional nucleophiles such as O-phenylenediamine,
ethylenediamine and their S- and O-analogues (13).
We have recently reported the cytotoxic activity of twenty-
six benzocycloheptoxazines (Table I, Figure 1) against
normal human oral cells (gingival fibroblast, pulp cell,
periodontal ligament fibroblast) and human squamous cell
carcinoma and promyelocytic leukemia HL-60 cell lines
(14). Among eighteen benzo[b]cyclohepta[e][1,4]oxazine
derivatives [6-23], 6,8,10-tribromo- [9], 6-bromo-2-methyl-
[20] and 6-bromo-2-chloro- [21] derivatives showed the
highest tumor-specific cytotoxicity. Compounds [9, 20, 21]
induced apoptotic cell death in HL-60 cells, whereas they
failed to induce apoptosis in HSC-4 cells (14). In order to
explore these anti-inflammatory agents, we investigated here
whether these twenty-six benzocycloheptoxazines (Table I,
Figure 1) inhibit NO production by lipopolysaccharide
(LPS)-stimulated RAW 264.7 cells.
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Materials and Methods
Materials. The following chemicals and reagents were obtained from
the companies indicated: Dulbecco’s modified Eagle’s medium
(DMEM), phenol red-free DMEM (Gibco BRL, Grand Island, NY,
USA); fetal bovine serum (FBS) (JRH Bioscience, Lenexa, KS,
USA); 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), LPS from Escherichia coli (Serotype 0111:B4) (Sigma Chem.
Co., St. Louis, MO, USA); 2-(4-carboxyphenyl)-4,4,5,5-tetramethyli-
midazoline-1-oxy1-3-oxide (carboxy-PTIO; a spin trap agent),
1-hydroxy-2-oxo-3-(N-3-methyl-3-aminopropyl)-3-methyl-1-triazene
(NOC-7; an NO generator) (Dojin, Kumamoto, Japan); dimethyl
sulfoxide (DMSO) (Wako Pure Chem. Ind., Ltd., Osaka, Japan).
Synthesis of benzocycloheptoxazines. Benzocycloheptoxazine
derivatives (Table I, Figure 1) were synthesized according to the
methods previously reported (14).
Cell culture. RAW 264.7 cells were cultured in DMEM
supplemented with 10% heat-inactivated FBS under a humidified
5% CO2 atmosphere.
Assay for NO production. RAW 264.7 cells were initially inoculated
at 6×104/0.1 ml in 96-microwell plates (Becton Dickenson, Labware,
NJ, USA). Media were replaced with fresh phenol red-free medium
supplemented with 10% FBS and different concentrations (0-100 or
500 μM) of test samples in the absence or presence of LPS (0.1
μg/ml), and incubated for a further 24 hours. The relative viable cell
number was then measured by the MTT method (12, 14, 15). The
50% cytotoxic concentration (CC50) was determined from the
dose–response curve. The NO produced in the culture medium was
quantified by Greiss reagent, using a standard curve of NO2 (12).
The concentration at which NO production was inhibited by 50%
(IC50) was determined from the dose–response curve. The extent of
the inhibition of NO production was monitored by the selectivity
index (SI) defined as follows: SI=CC50 / IC50.
Western blotting. The pelleted cells were lysed with 100 μl of lysis
buffer (10 mM Tris-HCl, pH 7.6, 1% Triton® X-100, 150 mM NaCl,
5 mM EDTA and 2 mM phenylmethylsulfonyl fluoride) for 10
minutes in iced water. The cell lysates were centrifuged at 16,000×g
for 20 minutes at 4˚C to remove insoluble materials and the
supernatant was collected. The protein concentrations of supernatants
were measured by Protein Assay Kit (Bio Rad, Hercules, CA, USA).
An equal amount of the protein from cell lysates (10 μg) was mixed
with 2x sodium dodecyl sulfate (SDS)-sample buffer [0.1 M Tris-
HCl (pH 6.8), 20% glycerol, 4% SDS, 0.01% bromophenol blue,
1.2% 2-mercaptoethanol], boiled for 10 minutes, applied to SDS-
8% polyacrylamide gel electrophoresis, and then transferred to
polyvinylidene difluoride (PVDF) membranes. The membranes were
blocked with 5% skimmed milk in phosphate-buffered saline
without Ca2+ and Mg2+ [PBS(–)] plus 0.05% Tween 20 for 90
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Table I. Effect of benzocycloheptoxazines on NO production by LPS-stimulated RAW 264.7 cells.
Compound MW CC50 (μM) ΙC50 (μM) SI
[1] benzo[b]cyclohepta[e][1,4]thiazine 211 >500 1.08±0.19 >463.0
[2] 6,8-dibromobenzo[b]cyclohepta[e][1,4]thiazine 369 20.1±1.27 1.09±0.16 18.4
[3] 6,8,10-tribromobenzo[b]cyclohepta[e][1,4]thiazine 448 21.0±4.29 5.02±0.97 4.2
[4] 6H-benzo[b]cyclohepta[e][1,4]diazine 194 >10 0.45±0.07 >22.4
[5] 6H-benzo[b]cyclohepta[e][1,4]diazine cation 254 >50 0.58±0.08 >86.9
[6] benzo[b]cyclohepta[e][1,4]oxazine 195 >100 1.14±0.28 >88.0
[7] 6-bromobenzo[b]cyclohepta[e][1,4]oxazine 274 >100 1.15±0.17 >86.9
[8] 6,8-dibromobenzo[b]cyclohepta[e][1,4]oxazine 353 >100 4.97±0.87 >20.1
[9] 6,8,10-tribromobenzo[b]cyclohepta[e][1,4]oxazine 432 >10 0.72±0.10 >13.8
[10] 8-bromobenzo[b]cyclohepta[e][1,4]oxazine 274 >100 5.92±0.32 >16.9
[11] 7-bromobenzo[b]cyclohepta[e][1,4]oxazine 274 98.1±1.68 3.39±0.16 28.9
[12] 9-bromobenzo[b]cyclohepta[e][1,4]oxazine 274 46.1±6.81 1.72±0.07 26.8
[13] 8-isopropylbenzo[b]cyclohepta[e][1,4]oxazine 236 91.7±11.7 3.33±0.42 27.6
[14] 9-isopropylbenzo[b]cyclohepta[e][1,4]oxazine 236 >100 4.77±0.63 >20.9
[15] 6-acetoxybenzo[b]cyclohepta[e][1,4]oxazine 253 96.2±6.64 4.15±0.68 23.2
[16] 8-acetoxybenzo[b]cyclohepta[e][1,4]oxazine 253 >10 0.62±0.07 >16.3
[17] 8-bromo-6-acetoxybenzo[b]cyclohepta[e][1,4]oxazine 332 >100 6.19±1.18 >16.2
[18] 9-acetoxybenzo[b]cyclohepta[e][1,4]oxazine 253 >100 1.51±0.09 >66.2
[19] 2-methylbenzo[b]cyclohepta[e][1,4]oxazine 209 95.9±7.16 4.08±0.27 23.5
[20] 6-bromo-2-methylbenzo[b]cyclohepta[e][1,4]oxazine 288 78.9±12.4 9.46±1.36 8.3
[21] 6-bromo-2-chlorobenzo[b]cyclohepta[e][1,4]oxazine 308 >10 1.39±0.06 >7.2
[22] 8-bromo-2-methylbenzo[b]cyclohepta[e][1,4]oxazine 288 >100 4.93±0.58 >22.8
[23] 8-bromo-2-chlorobenzo[b]cyclohepta[e][1,4]oxazine 308 >100 12.0±0.20 >9.1
[24] 14H-[1,4]benzoxazino[3’,2’:3,4]cyclohepta[1,2-b][1,4]benzoxazine 300 >100 1.50±0.11 >66.7
[25] 14H-7-bromo[1,4]benzoxazino[3’,2’:3,4]cyclohepta[1,2-b][1,4]benzoxazine 379 >10 0.35±0.05 >28.7
[26] 14H-7-isopropyl[1,4]benzoxazino[3’,2’:3,4]cyclohepta[1,2-b][1,4]benzoxazine 342 >10 0.19±0.02 >52.9
MW: Molecular weight; CC50: 50% cytotoxic concentration; IC50: concentration at which NO production was inhibited by 50% ; SI: Selectivity
index (CC50/IC50). Each value represents the mean from 3 independent experiments.
minutes and incubated for 90 minutes at room temperature with anti-
iNOS antibody (1:1,000; Santa Cruz Biotechnology, Delaware, CA,
USA), or anti-actin antibody (1:2000-4000; Sigma), and then
incubated with horseradish peroxidase-conjugated anti-rabbit or
mouse IgG for 90 minutes at room temperature. Immunoblots were
developed with a Western Lightning™ Chemiluminescence Reagent
Plus (Perkin Elmer Life Sciences, Boston, MA, USA) (15).
NO radical scavenging activity. The radical intensity of benzocyclo-
heptoxazines was determined at 25˚C, using electron spin resonance
(ESR) spectroscopy (JEOL JES REIX Tokyo, Japan, X-band, 100 kHz
modulation frequency) (15). The radical intensity of NO, produced
from the reaction mixture of 20 μM carboxy-PTIO and 60 μM NOC-
7, was determined in 0.1 M phosphate buffer, pH 7.4 in the presence
of 30% DMSO (microwave power and gain were changed to 5 mW
and 400, respectively). When NOC-7 and carboxy-PTIO were mixed,
NO was oxidized to NO2 and carboxy-PTIO was reduced to carboxy-
PTI, which produces seven-line signals. Samples were added 3
minutes after mixing. The NO radical intensity was defined as the ratio
of the signal intensity of the first peak of carboxy-PTI to that of MnO
an external marker, and expressed as the ratio to the height of MnO.
The concentration that reduced the NO radical intensity by 50%
(EC50) was determined from the dose-response curve.
Results
Inhibition of NO production. LPS (0.1 μg/ml) significantly
stimulated NO production by RAW 264.7 cells, and the NO
released into the culture medium was elevated from the
background level to approximately 39 μM (data not shown).
Benzocycloheptoxazine alone did not significantly induce NO
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Figure 1. Structures of twenty-six benzocycloheptoxazines used in this study.
production by unstimulated RAW 264.7 cells (data not shown),
but effectively inhibited the NO production by LPS-stimulated
RAW 264.7 cells. Among twenty-six benzocyclo-heptoxazine
derivatives, benzo[b]cyclohepta[e][1,4]thiazine [1] potently
inhibited the NO production by the activated RAW 264.7 cells
(IC50=1.08 μM), and its cytotoxicity was detected only at two
orders higher concentrations (CC50>500 μM) (Figure 2A),
yielding the highest selectivity index (SI>463.0) (Table I).
Although 14H-7-isopropyl[1,4] benzoxazino[3’,2’:3,4]
cyclohepta[1,2-b][1,4]benzoxazine [26] has the lowest IC50 and
therefore is most potent at NO inhibition, it is more cytotoxic
(CC50>10 μM) than [1], yielding a lower selectivity index
(SI>52.9) (Table I). Compounds [2, 3], that is 6,8-dibromo and
6,8,10-tribromo derivatives of [1], respectively, exhibited higher
cytotoxicity (CC50=20-21 μM), and therefore much lower SI
values (SI=18.4 and 4.2, respectively) (Figure 2B, Table I). 6H-
Benzo[b]cyclohepta[e][1,4]diazine cation [5], and benzo[b]
cyclohepta[e][1,4]oxazine [6] and its 6-bromo derivative [7]
also exhibited higher SI values. Another sixteen benzo[b]
cyclohepta[e][1,4]oxazines [8-23] and 14H-[1,4]benzoxazino
[3’,2’:3,4]cyclohepta[1,2-b][1,4]benzoxazine [24] and its
7-bromo-[25] and 7-isopropyl- [26] derivatives also inhibited
LPS-stimulated NO production to slightly lower extents
(SI=8.3-66).
Effect on iNOS level. Compounds [1, 2] did not reduce the
intracellular level of inducible NO synthase, as shown by
Western blot analysis (Figure 3A, 3B).
NO scavenging activity. ESR spectroscopy showed that
compound [1] dose-dependently scavenged the NO radical
produced by NOC-7, with an EC50 of 485 μM (Figure 4A).
The NO scavenging activity of [2] was much less
(EC50>1219 μM) (Figure 4B).
Discussion
Benzo[b]cyclohepta[e][1,4]thiazine [1] effectively inhibited the
NO production by LPS-stimulated RAW 264.7 cells (SI>463),
without showing any apparent cytotoxicity (CC50>500 μM).
The introduction of two or three bromines at the C-6 and -8
positions, or at the C-6, -8, and -10 positions of the
cycloheptane ring [2, 3] significantly enhanced the cytotoxicity
and therefore showed much lower inhibition of NO production,
as revealed by the reduction of the SI values (18.4 and 4.2,
respectively). This finding is consistent with our previous
report that bromination of benzo[b]cyclohepta[e][1,4]thiazine
[1] resulted in significant enhancement of its cytotoxicity
against both normal and tumorous human cells (14).
Similarly, the inhibitory effect of benzo[b]cyclohepta
[e][1,4]oxazine [6] on NO production by LPS-activated RAW
264.7 cells (SI>88.0) was reduced by bromination at the C-6
and -8 positions [8] (SI>20.1), and at the C-6, -8, and -10
positions [9] (SI>13.8). The inhibitory effect of 2-
methylbenzo[b]cyclohepta[e][1,4]oxazine [19] (SI=23.5) was
also reduced by bromination at the C-6 position [20] (SI=8.3)
(Table I). These data suggest negative correlation between the
cytotoxicity of benzocycloheptoxazines and the inhibitory
activity against NO production by activated macrophages.
We have previously reported that compounds [9, 20, 21]
showed the highest tumor-specific cytotoxicity (14). The
present study, however, demonstrated that these compounds
inhibited the LPS-stimulated NO production to a much lesser
extent (SI=>13.8, 8.3, >7.2, respectively) (Table I). This
suggests the lack of a correlation between the tumor
specificity and the inhibitory activity against the NO
production by activated macrophages.
There are two possibilities that explain the decline of the NO
production by activated macrophages: either NO production is
inhibited or NO degradation is increased. ESR demonstrated that
the second possiblity can be rejected, since the NO scavenging
activity of [1, 2] was very weak. Therefore, the first possibility
should be considered. So far, we found that compounds [1, 2]
failed to reduce the intracellular concentration of iNOS. The
ANTICANCER RESEARCH 28: 2657-2662 (2008)
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Figure 2. Inhibition of NO production by LPS-stimulated RAW 264.7
cells by benzocycloheptoxazines. Near confluent RAW 264.7 cells were
incubated for 24 hours without (control), or with the indicated
concentrations of benzo[b]cyclohepta[e][1,4]thiazine [1] (A) or its 6,8-
dibromo derivative [2] (B) in the presence of 0.1 μg/mL LPS in phenol
red-free DMEM supplemented with 10% FBS. The viable cell number
() and extracellular concentration of NO () were then determined
by MTT assay and Griess reagent, respectively. Each value (expressed
as %  of control) represents mean±S.D. of triplicate assays.
possibility that these compounds may inactivate iNOS activity
remains to be investigated. Whatever the underlying mechanism,
the present study suggests the possible anti-inflammatory action
of benzocyclo-heptoxazines, based on their inhibition of LPS
action against macrophages. To test whether benzocyclo-
heptoxazines actually has any anti-inflammatory action, the
effects on prostaglandin production and cyclooxygenase
expression in the activated macrophages should be investigated.
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